The Innovative Medicines Initiative (imi) - Cancer Science

Relevant Publications

Replication, safety and immunogenicity of the vectored Ebola vaccine rVSV-ΔG-ZEBOV-GP in a sub-Saharan African paediatric population: a randomised controlled, open-label trial in children aged 1-12 years living in Lambaréné, Gabon.

Issue Release: 2024

A Federated Database for Obesity Research: An IMI-SOPHIA Study.

Issue Release: 2024

Role of human plasma metabolites in prediabetes and type 2 diabetes from the IMI-DIRECT study.

Issue Release: 2024

Building a Sustainable Learning Health Care System for Pregnant and Lactating People: Interview Study Among Data Access Providers.

Issue Release: 2024

Performance of biomarkers NF-L, NSE, Tau and GFAP in blood and cerebrospinal fluid in rat for the detection of nervous system injury.

Issue Release: 2024

The association of cardiometabolic, diet and lifestyle parameters with plasma glucagon-like peptide-1: An IMI DIRECT study.

Issue Release: 2024

Past and future of an IMI-PharmaTrain (IMI-PhT)-initiated multinational pharmaceutical medicine course at the Semmelweis University in Hungary.

Issue Release: 2024

Proteomic signatures of eosinophilic and neutrophilic asthma from serum and sputum.

Issue Release: 2023

Altered blood gene expression in the obesity-related type 2 diabetes cluster may be causally involved in lipid metabolism: a Mendelian randomisation study.

Issue Release: 2023

Electronic health records (EHRs) in clinical research and platform trials: Application of the innovative EHR-based methods developed by EU-PEARL.

Issue Release: 2023

Core Data Elements for Pregnancy Pharmacovigilance Studies Using Primary Source Data Collection Methods: Recommendations from the IMI ConcePTION Project.

Issue Release: 2023

Participating in innovative medicines initiative funded neurodegenerative disorder projects-An impact analysis conducted as part of the NEURONET project.

Issue Release: 2023

Brand-specific estimates of influenza vaccine effectiveness for the 2021-2022 season in Europe: results from the DRIVE multi-stakeholder study platform.

Issue Release: 2023

Patients as research partners in preference studies: learnings from IMI-PREFER.

Issue Release: 2023

Developing consensus on core outcome sets of domains for acute, the transition from acute to chronic, recurrent/episodic, and chronic pain: results of the INTEGRATE-pain Delphi process.

Issue Release: 2023

Regulatory Qualification of a Cross-Disease Digital Measure: Benefits and Challenges from the Perspective of IMI Consortium IDEA-FAST.

Issue Release: 2023

European Projects for Patients with Dementia and Their Caregivers.

Issue Release: 2023

Setting International Standards in Analyzing Patient-Reported Outcomes and Quality of Life Endpoints in Cancer Clinical Trials-Innovative Medicines Initiative (SISAQOL-IMI): stakeholder views, objectives, and procedures.

Issue Release: 2023

Single-arm studies involving patient-reported outcome data in oncology: a literature review on current practice.

Issue Release: 2023

Application of clinical and molecular profiling data to improve patient outcomes in psoriatic arthritis.

Issue Release: 2023

What role do biomarkers play in cancer treatment?

How Do Blister Packs Benefit Cancer Patients?

How to Prepare for Bone Marrow Aspiration?

What are the Benefits of Telemedicine in Cancer Care?

Which Types of Cancer Are Most Commonly Associated with Dysphagia?

How do Keratins Affect Tumor Behavior?

Which Cancers are Associated with MSI-H?

What are the Challenges in Using Natural Compounds for Cancer Treatment?

How is Processed Meat Linked to Cancer?

Why is Tumor Location Important in Cancer?

The Innovative Medicines Initiative (imi) - Cancer Science

Relevant Publications

Partnered Content Networks

Relevant Topics